Contribution of Fas ligand to T cell-mediated hepatic injury in mice

被引:131
作者
Seino, KI
Kayagaki, N
Takeda, K
Fukao, K
Okumura, K
Yagita, H
机构
[1] JUNTENDO UNIV,SCH MED,DEPT IMMUNOL,BUNKYO KU,TOKYO 113,JAPAN
[2] UNIV TSUKUBA,SCH MED,DEPT SURG,IBARAKI,OSAKA,JAPAN
关键词
D O I
10.1053/gast.1997.v113.pm9322527
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Fas has been implicated in liver damage, The aim of this study was to investigate the role of its ligand to induce hepatocyte death and liver damage in T cell-dependent hepatitis, Methods: Fas ligand-mediated lysis of primary hepatocytes from C57BL/6 wild-type, Fas ligand-deficient gld, and Fas-deficient lpr mice and concanavalin A-induced hepatitis in these mice were assessed. Results: Freshly isolated hepatocytes from wild-type or gld mice, but not those from lpr mice, were susceptible to Fas ligand-mediated lysis, When concanavalin A was intravenously administered into wild-type mice, they developed acute hepatic injury with massive degenerative changes in hepatocytes, In contrast, both gld and lpr mice had lower aminotransferase levels with milder histological changes, Reverse-transcription polymerase chain reaction and flow cytometric analysis showed that Fas ligand was induced in the liver shortly after the concanavalin A injection and was predominantly expressed on intrahepatic T cells, Administration of monoclonal antibody neutralizing mouse Fas ligand could reduce the aminotransferase increase, Conclusions: The results indicate that Fas ligand plays a role in the T cell-dependent hepatitis induced by concanavalin A administration.
引用
收藏
页码:1315 / 1322
页数:8
相关论文
共 41 条
[1]   MECHANISMS OF CLASS-I RESTRICTED IMMUNOPATHOLOGY - A TRANSGENIC MOUSE MODEL OF FULMINANT-HEPATITIS [J].
ANDO, K ;
MORIYAMA, T ;
GUIDOTTI, LG ;
WIRTH, S ;
SCHREIBER, RD ;
SCHLICHT, HJ ;
HUANG, SN ;
CHISARI, FV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1541-1554
[2]   FAS-MEDIATED CYTOTOXICITY BY FRESHLY ISOLATED NATURAL-KILLER-CELLS [J].
ARASE, H ;
ARASE, N ;
SAITO, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) :1235-1238
[3]   FAS AND TUMOR-NECROSIS-FACTOR RECEPTOR-MEDIATED CELL-DEATH - SIMILARITIES AND DISTINCTIONS [J].
CLEMENT, MV ;
STAMENKOVIC, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (02) :557-567
[4]  
DING AH, 1988, J IMMUNOL, V141, P2407
[5]   INVOLVEMENT OF THE CD95 (APO-1/FAS) RECEPTOR AND LIGAND IN LIVER-DAMAGE [J].
GALLE, PR ;
HOFMANN, WJ ;
WALCZAK, H ;
SCHALLER, H ;
OTTO, G ;
STREMMEL, W ;
KRAMMER, PH ;
RUNKELL, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1223-1230
[6]  
GANTNER F, 1995, HEPATOLOGY, V21, P190, DOI 10.1002/hep.1840210131
[7]   TUMOR NECROSIS FACTOR-INDUCED HEPATIC DNA FRAGMENTATION AS AN EARLY MARKER OF T-CELL-DEPENDENT LIVER-INJURY IN MICE [J].
GANTNER, F ;
LEIST, M ;
JILG, S ;
GERMANN, PG ;
FREUDENBERG, MA ;
TIEGS, G .
GASTROENTEROLOGY, 1995, 109 (01) :166-176
[8]   ISOLATION AND FLOW CYTOMETRIC ANALYSIS OF THE FREE LYMPHOMYELOID CELLS PRESENT IN MURINE LIVER [J].
GOOSSENS, PL ;
JOUIN, H ;
MARCHAL, G ;
MILON, G .
JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 132 (01) :137-144
[9]   Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes [J].
Guidotti, LG ;
Ishikawa, T ;
Hobbs, MV ;
Matzke, B ;
Schreiber, R ;
Chisari, FV .
IMMUNITY, 1996, 4 (01) :25-36
[10]   THE POLYPEPTIDE ENCODED BY THE CDNA FOR HUMAN CELL-SURFACE ANTIGEN FAS CAN MEDIATE APOPTOSIS [J].
ITOH, N ;
YONEHARA, S ;
ISHII, A ;
YONEHARA, M ;
MIZUSHIMA, S ;
SAMESHIMA, M ;
HASE, A ;
SETO, Y ;
NAGATA, S .
CELL, 1991, 66 (02) :233-243